Related Experiment Video
Updated: Aug 11, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
[Depression and coronary artery disease]
1Hôpital de Jour Universitaire La Clé, CHU de Liège.
Insights
Depression is a significant risk factor for coronary artery disease (CAD) and increases its mortality. Selective serotonin reuptake inhibitors (SSRIs) offer a safe and effective treatment for depression in heart disease patients, potentially improving outcomes.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Context:
- Depression and cardiovascular diseases (CVDs) are leading global health concerns.
- Depression is an established risk factor for developing coronary artery disease (CAD) in healthy individuals.
- Depression exacerbates morbidity and mortality in patients already diagnosed with CAD.
Purpose:
- To review the relationship between depression and cardiovascular diseases.
- To evaluate the efficacy and safety of selective serotonin reuptake inhibitors (SSRIs) in treating depression among cardiac patients.
- To explore the potential cardioprotective effects of SSRI treatment.
Summary:
- SSRIs are demonstrated to be a safe and effective treatment option for patients experiencing both depression and heart disease.
- Evidence suggests that treating depression with SSRIs may confer a protective effect against myocardial infarction (MI).
- SSRI intervention in depressed cardiac patients may lead to improved clinical outcomes, including reduced mortality.
Impact:
- Highlights the critical link between mental health and cardiovascular health.
- Supports the use of SSRIs as a therapeutic strategy in managing depressed patients with heart conditions.
- Suggests potential benefits of depression treatment in mitigating cardiovascular event risk and improving patient survival.
Abstract:
Depression and cardiovascular diseases represent a major public health problem worldwide. Recent studies have shown that depression is a risk factor for the development of coronary artery disease (CAD) in healthy people and also increases morbidity and mortality in depressed patients with CAD. Others studies have shown that selective serotonin inhibitors (SSRIs) constitute a safe and effective treatment for depressed patients with heart disease. There are also data suggesting that treating depression with SSRIs has a protective role in myocardial infarction and may improve outcomes, including mortality.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...